Hemofiltration in sepsis: where do we go from here?
Hemofiltration as an adjunct to therapy for sepsis is now 10 years old. Despite early successes and significant theoretical advantages, the treatment remains experimental. Although feasibility has been established, efficacy has proved to be much more difficult. Clinical as well as technical...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2000
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137329/ |